Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11526 posts found.

steve_turley_linkedin

UCB appoints Steve Turley as MD for Britain and Ireland

November 18, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing UCB

Steve Turley has joined UCB as the company’s managing director for the British and Irish isles, moving from Lundbeck. He …
Appointment

DJM PAN Unlimited adds client services director

November 17, 2015 Manufacturing and Production, Sales and Marketing

Wyndham Clark has joined the board of DJM PAN Unlimited as client services director. Previously, Clark was client services director …
Appointment

NICE rejects Roche’s Kadcyla for NHS; price still too high

November 17, 2015 Manufacturing and Production, Sales and Marketing Cancer Drugs Fund, Kadcyla, NHS England, NICE, Roche

NICE has published final draft guidance on Roche’s Kadcyla as a breast cancer treatment, deciding that the drug’s price remains …
News
baxalta_logo

FDA approves Baxalta Haemophilia A treatment

November 16, 2015 Manufacturing and Production, Research and Development, Sales and Marketing

The US FDA has approved Baxalta’s twice-weekly therapy Adynovate for use in adults and adolescents, aged 12 years plus, with …
News
andrew_lansley_300

Former Health Secretary Andrew Lansley takes on Roche advisory role

November 16, 2015 Medical Communications, Sales and Marketing

Former UK health secretary Andrew Lansley has taken on work as an advisor to Roche in the midst of ongoing …
News
diabetes_insulin_syringes

Novo Nordisk invests $20m in diabetes research following study

November 16, 2015 Research and Development, Sales and Marketing

Novo Nordisk has unveiled plans to combat urban diabetes in a $20 million investment offering expert resources and research funds …
News
amgen_flag

Amgen’s Humira biosimilar succeeds in Phase III arthritis study

November 16, 2015 Research and Development, Sales and Marketing Amgen, Humira

Amgen says its Humira (adalimumab) biosimilar candidate ABP 501 proved its clinical equivalence to Abbvie’s blockbuster drug in a head-to-head …
News

Takeda UK strengthens its senior leadership team

November 16, 2015 Medical Communications, Sales and Marketing

Takeda UK is bolstering its Medical and Human Resources functions as Takeda continues to develop its expertise in the Specialty …
Appointment
perrigo

Perrigo rejects $26 billion hostile Mylan takeover bid

November 13, 2015 Medical Communications, Sales and Marketing Mylan, Perrigo, mergers and acquisitions

Perrigo has rejected Mylan’s hostile $26 billion bid after a 60% majority of shareholders were unconvinced by the terms by …
News
Gilead image

FDA expands Gilead’s Harvoni indications for Hep C

November 13, 2015 Sales and Marketing Gilead, Gilead Sciences, harvoni, ledipasvir-sofosbuvir

Gilead’s Harvoni has been approved by the FDA for expanded use in patients with genotypes 4, 5 and 6 chronic …
News
mene_pangalos

New appointments for AstraZeneca’s Mene Pangalos

November 13, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Dr Mene Pangalos, executive vice president of the IMED Biotech Unit at AstraZeneca UK, has accepted two prestigious appointments that …
Appointment
Scotland flag

Three new drugs approved for use in Scotland

November 12, 2015 Sales and Marketing Scottish Medicines Consortium

The Scottish Medicines Consortium (SMC) has given the go-ahead for the use of several drugs on the NHS in Scotland. …
News
Benlysta

GSK ready for lupus drug push

November 12, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Benlysta, GSK, Lupus, SLE, belimumab, systemic lupus erythematosus

Having presented positive late-stage results for a new formulation of its inflammatory drug Benlysta, GSK says it will file supplementary …
News
new Merck sign

Merck achieves 7% sales growth in Q3 2015

November 12, 2015 Sales and Marketing Merck, Rebif, financial results

German pharma group Merck has earned a 7% bump in its sales, and a 10% boost in earnings before deductions, …
News
MSF poster

MSF launches global action against GSK and Pfizer over pneumonia vaccine price

November 12, 2015 Manufacturing and Production, Sales and Marketing Doctors Without Borders, GSK, MSF, Médecins Sans Frontières, Pfizer, Synflorix, pneumococcal vaccine, pneumonia, prevenar 13, vaccines

International medical aid charity Médecins Sans Frontières/Doctors Without Borders (MSF) is taking action against GlaxoSmithKline and Pfizer, calling on the …
News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026